# ResMed

> ResMed makes connected sleep and breathing devices, masks, diagnostics and healthcare software. Its business combines equipment sales, replacement supplies and software subscriptions, serving patients through clinicians, home medical equipment providers and distributors in more than 140 countries.

- **Founded:** 1989
- **Headquarters:** San Diego, United States
- **Founders:** Peter Farrell (Founder and founding CEO; now chair emeritus)
- **Products:** AirSense 11, AirMini, AirTouch F30i Comfort, AirFit and AirTouch masks, AirCurve and Astral
- **Notable:** Commercialized PAP technology through a company founded in 1989., Introduced the cloud-connectable Air10 line in 2014., Reported fiscal 2026 revenue growth of 10% and free cash flow of about US$1.6 billion.

## Products & services

- **AirSense 11** — Connected PAP platform with touchscreen controls, humidification and access to myAir support; controlled introduction began in fiscal 2021.
- **AirMini** — Portable PAP device with app controls and waterless humidification options.
- **AirTouch F30i Comfort** — Full-face CPAP mask with a fabric-and-silicone cushion and fabric-wrapped frame; launched in the U.S. in February 2026.
- **AirFit and AirTouch masks** — Nasal, nasal-pillow and full-face interfaces, with replacement cushions and accessories.
- **AirCurve and Astral** — Bilevel and ventilation product families for appropriate respiratory-care indications.
- **AirView** — Provider platform for remote therapy monitoring and device-setting management.
- **myAir** — Patient app offering therapy feedback, setup guidance and coaching.
- **Smart Comfort** — FDA-cleared software recommending personalized non-prescription comfort settings; introduced to select new myAir users in early 2026.
- **NightOwl** — Connected home sleep-testing technology acquired with Ectosense in 2021.
- **Brightree** — Clinical, billing and business software for home medical equipment providers.
- **MEDIFOX DAN** — Care-management software serving residential care providers in Germany.
- **Noctrix / Nidra** — Wearable therapy for refractory moderate-to-severe restless legs syndrome; Noctrix acquired in June 2026.

## Achievements

- Commercialized PAP technology through a company founded in 1989.
- Introduced the cloud-connectable Air10 line in 2014.
- Reported fiscal 2026 revenue growth of 10% and free cash flow of about US$1.6 billion.
- Smart Comfort received FDA clearance in December 2025.
- Built a distribution footprint spanning more than 140 countries.

## Latest updates

- **2026-09** — MatrixCare divestiture closed September 1, following a US$490 million sale agreement with Frazier Healthcare Partners.
- **2026-08** — Reported fiscal 2026 revenue of US$5.653 billion, up 10% on a reported basis.
- **2026-06** — Completed the Noctrix acquisition, publicly described as a US$340 million transaction.
- **2026-05** — Announced sleep-health education and care-pathway partnership with ŌURA.
- **2026-02** — Launched AirTouch F30i Comfort in the United States.

## Links

- Website: https://www.resmed.com/
- LinkedIn: https://www.linkedin.com/company/resmed
- Twitter/X: https://x.com/Resmed
- YouTube: https://www.youtube.com/channel/UCwjFC_AikD4--KeVnU7mbJg
- Instagram: https://www.instagram.com/resmed
- Facebook: https://www.facebook.com/ResMedAmericas/

---

Profile page: https://yespress.io/resmed
Published by YesPress — https://yespress.io
Last updated: 2026-10-22